Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge

Neuropsychopharmacology

Volumn 33, Issue 2, 2008, Pages 441-456

  Meyer, Urs ^a   Nyffeler, Myriel ^a   Schwendener, Severin ^a   Knuesel, Irene ^a,b   Yee, Benjamin K ^a   Feldon, Joram ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adoption; Dopamine; Glutamate; Infection; Neurodevelopment; Pregnancy

Indexed keywords

AMPHETAMINE; DIZOCILPINE; DOPAMINE; GLUTAMIC ACID; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; INFLAMMATION; LOCOMOTION; MALE; MOTHER; MOUSE; NEUROANATOMY; NEUROCHEMISTRY; NEWBORN; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRENATAL DRUG EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; SCHIZOPHRENIA;

AMIDINES; ANIMALS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MATERNAL BEHAVIOR; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PATERNAL BEHAVIOR; POLY I-C; PREGNANCY; PREGNANCY COMPLICATIONS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 36949028725     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301413     Document Type: Article

References (74)

1. Bacopoulos NG, Bhatnagar RK (1977). Correlation between tyrosine hydroxylase activity and catecholamine concentration or turnover in brain regions. J Neurochem 29: 639-643.
2. Borrell J, Vela JM, Arévalo-Martin A, Molina-Holgado E, Guaza C (2002). Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26: 204-221.
3. Brake WG, Zhang TY, Diorio J, Meaney MJ, Gratton A (2004). Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioural responses to psychostimulants and stressors in adult rats. Eur J Neurosci 19: 1863-1874.
4. Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V et al (2004). Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 161: 889-895.
5. Brown AS, Susser ES (2002). In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 8: 51-57.
6. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH (2001). Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 15: 411-420.
7. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001). Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41: 237-260.
8. Carlsson M, Carlsson A (1989). The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75: 221-226.
9. Chartoff EH, Heusner CL, Palmiter RD (2005). Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology 30: 1324-1333.
10. Cirulli F, Berry A, Alleva E (2003). Early disruption of the mother-infant relationship: effects on brain plasticity and implications for psychopathology. Neurosci Biobehav Rev 27: 73-82.
11. Creese I, Iversen SD (1975). The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83: 419-436.
12. Cull-Candy S, Brickley S, Farrant M (2001). NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11: 327-335.
13. Curfs JH, Meis JF, Hoogkamp-Korstanje JA (1997). A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev 10: 742-780.
14. Fatemi SH (2005). Neuropsychiatric Disorders and Infection. Taylor & Francis: London.
15. Fortier ME, Joober R, Luheshi GN, Boksa P (2004a). Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 38: 335-345.
16. Fortier ME, Kent S, Ashdown H, Poole S, Boksa P, Luheshi GN (2004b). The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 287: R759-R766.
17. French ED, Mura A, Wang T (1993). MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists. Synapse 13: 108-116.
18. Fritschy JM, Weinmann O, Wenzel A, Benke D (1998). Synapse-specific localization of NMDA and GABA(A) receptor subunits revealed by antigen-retrieval immunohistochemistry. J Comp Neurol 390: 194-210.
19. Gilmore JH, Jarskog LF (1997). Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 24: 365-367.
20. Gilmore JH, Jarskog LF, Vadlamudi S, Lauder JM (2004). Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development. Neuropsychopharmacology 29: 1221-1229.
21. Haddad JJ, Saade NE, Safieh-Garabedian B (2002). Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary- adrenal revolving axis. J Neuroimmunol 133: 1-19.
22. Harte M, O'Connor WT (2004). Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat. Brain Res 1017: 120-129.
23. Heidbreder C, Feldon J (1998). Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 29: 310-322.
24. Herlenius E, Lagercrantz H (2004). Development of neurotransmitter systems during critical periods. Exp Neurol 190: S8-S21.
25. Holcomb HH, Lahti AC, Medoff DR, Cullen T, Tamminga CA (2005). Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology 30: 2275-2282.
26. Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH (1997). Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int J Dev Neurosci 15: 711-776.
27. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
28. Kimura M, Toth LA, Agostini H, Cady AB, Majde JA, Krueger JM (1994). Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA. Am J Physiol 267: R1596-R1605.
29. Kohr G (2006). NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res 326: 439-446.
30. Kretschmer BD (1999). Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors. J Neurochem 73: 839-848.
31. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
32. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9-19.
33. Laruelle M (2000). The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Rev 31: 371-384.
34. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J et al (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93: 9235-9240.
35. Lieberman JA, Kane JM, Alvir J (1987). Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology 91: 415-433.
36. Ling ZD, Potter ED, Lipton JW, Carvey PM (1998). Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol 149: 411-423.
37. Lu W, Chen H, Xue CJ, Wolf ME (1997). Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex. Synapse 26: 269-280.
38. Lu W, Wolf ME (1999). Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex. Synapse 32: 119-131.
39. Lujan R, Shigemoto R, Lopez-Bendito G (2005). Glutamate and GABA receptor signalling in the developing brain. Neuroscience 130: 567-580.
40. Mathe JM, Nomikos GG, Hildebrand BE, Hertel P, Svensson TH (1996). Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur J Pharmacol 309: 1-11.
41. Meek LR, Dittel PL, Sheehan MC, Chan JY, Kjolhaug SR (2001). Effects of stress during pregnancy on maternal behavior in mice. Physiol Behav 72: 473-479.
42. Meyer U, Feldon J, Schedlowski M, Yee BK (2005). Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29: 913-947.
43. Meyer U, Feldon J, Schedlowski M, Yee BK (2006a). Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun 20: 378-388.
44. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I et al (2006b). The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26: 4752-4762.
45. Meyer U, Schwendener S, Feldon J, Yee BK (2006c). Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res 173: 243-257.
46. Meyer U, Yee BK, Feldon J (2007). The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist (in press).
47. Miller MT, Stromland K, Ventura L, Johansson M, Bandim JM, Gillberg C (2005). Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int J Dev Neurosci 23: 201-219.
48. Murase S, Mathe JM, Grenhoff J, Svensson TH (1993). Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. J Neural Transm Gen Sect 91: 13-25.
49. Nawa H, Takei N (2006). Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56: 2-13.
50. Nieoullon A (2002). Dopamine and the regulation of cognition and attention. Prog Neurobiol 67: 53-83.
51. Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M (2006). Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59: 546-554.
52. Patin V, Lordi B, Vincent A, Thoumas JL, Vaudry H, Caston J (2002). Effects of prenatal stress on maternal behavior in the rat. Dev Brain Res 139: 1-8.
53. Peleg-Raibstein D, Sydekum E, Russig H, Feldon J (2006). Withdrawal from continuous amphetamine administration abolishes latent inhibition but leaves prepulse inhibition intact. Psychopharmacology 185: 226-239.
54. Peterson JD, Wolf ME, White FJ (2006). Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex. J Neurosci 26: 3164-3168.
55. Pijnenburg AJ, Honig WM, Van der Heyden JA, Van Rossum JM (1976). Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35: 45-58.
56. Pryce CR, Feldon J (2003). Long-term neurobehavioural impact of the postnatal environment in rats: manipulations, effects and mediating mechanisms. Neurosci Biobehav Rev 27: 57-71.
57. Rasier G, Toppari J, Parent AS, Bourguignon JP (2006). Female sexual maturation and reproduction after prepubertal exposure to estrogens and endocrine disrupting chemicals: a review of rodent and human data. Mol Cell Endocrinol 254-255: 187-201.
58. Rodier PM, Hyman SL (1998). Early environmental factors in autism. Men Retard Dev Disabil Res Rev 4: 121-128.
59. Russig H, Murphy CA, Feldon J (2005). Behavioural consequences of withdrawal from three different administration schedules of amphetamine. Behav Brain Res 165: 26-35.
60. Shi L, Fatemi SH, Sidwell RW, Patterson PH (2003). Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23: 297-302.
61. Sisk CL, Foster DL (2004). The neural basis of puberty and adolescence. Nat Neurosci 7: 1040-1047.
62. Spanagel R, Weiss F (1999). The dopamine hypothesis of reward: past and current status. Trends Neurosci 22: 521-527.
63. Spear LP (2000). The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463.
64. Sullivan R, Wilson DA, Feldon J, Yee BK, Meyer U, Richter-Levin G et al (2006). The international society for developmental psychobiology annual meeting symposium: impact of early life experiences on brain and behavioral development. Dev Psychobiol 48: 583-602.
65. Tzschentke TM (2001). Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63: 241-320.
66. Vezina P, Blanc G, Glowinski J, Tassin JP (1991). Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: a role for the cortical D-1 dopamine receptor. Eur J Neurosci 3: 1001-1007.
67. Vezina P, Blanc G, Glowinski J, Tassin JP (1994). Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse 16: 104-112.
68. Webster JI, Sternberg EM (2004). Role of the hypothalamic-pituitary- adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products. J Endocrinol 181: 207-221.
69. Weiner I (2003). The 'two-headed' latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169: 257-297.
70. Wolf ME (1998). The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54: 679-720.
71. Wu J, Zou H, Strong JA, Yu J, Zhou X, Xie Q et al (2005). Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice. Psychopharmacology 177: 256-263.
72. Yan QS, Reith ME, Jobe PC, Dailey JW (1997). Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res 765: 149-158.
73. Zuckerman L, Rehavi M, Nachman R, Weiner I (2003). Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28: 1778-1789.
74. Zuckerman L, Weiner I (2005). Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39: 311-323.